Fixed Airflow Obstruction among Nonsmokers with Asthma:A Case-Comparison Study

Bibliography

• Eder W, Ege MJ, von Mutius E. The asthma epidemic. N Engl J Med 2006; 355(21):2226–2235.
   PubMed Web of Science ®Google Scholar
• Dijkstra A, Vonk JM, Jongepier H, Koppelman GH, Schouten JP, ten Hacken NHT, Timens W, Postma DS. Lung function decline in asthma: Association with inhaled corticosteroids, smoking and sex. Thorax 2006; 61(2):105–110.
   PubMed Web of Science ®Google Scholar
• Ulrik CS, Lange P. Decline of lung function in adults with bronchial asthma. Am J Respir Crit Care Med 1994; 150(3):629–634.
   PubMed Web of Science ®Google Scholar
• de Marco R, Accordini S, Marcon A, Cerveri I, Antó JM, Gislason T, Heinrich J, Janson C, Jarvis D, Kuenzli N, Leynaert B, Sunyer J, Svanes C, Wjst M, Burney P, the European Community Respiratory Health Survey (ECRHS). Risk factors for Chronic Obstructive Pulmonary Disease in a European cohort of young adults. Am J Respir Crit Care Med 2011; 183:891–897.
   PubMed Web of Science ®Google Scholar
• Eisner MD, Anthonisen N, Coultas D, Kuenzli N, Perez-Padilla R, Postma D, Romieu I, Silverman EK, Balmes JR, Committee on Nonsmoking COPD, Environmental and Occupational Health Assembly. An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010; 182(5):693–718.
   PubMed Web of Science ®Google Scholar
• Lamprecht B, McBurnie MA, Vollmer WM, Gudmundsson G, Welte T, Nizankowska-Mogilnicka E, Studnicka M, Bateman E, Anto JM, Burney P, Mannino DM, Buist SA, the BOLD Collaborative Research Group. COPD in never smokers: Results from the population-based burden of obstructive lung disease study. Chest 2011; 139(4):752–763.
   PubMed Web of Science ®Google Scholar
• Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet 2009; 374(9691):733–743.
   PubMed Web of Science ®Google Scholar
• Balmes J, Becklake M, Blanc P, Henneberger P, Kreiss K, Mapp C, Milton D, Schwartz D, Toren K, Viegi G. American thoracic society statement: Occupational contribution to the burden of airway disease. Am J Respir Crit Care Med 2003; 167(5):787–797.
   PubMed Web of Science ®Google Scholar
• Po JYT, FitzGerald JM, Carlsten C. Respiratory disease associated with solid biomass fuel exposure in rural women and children: Systematic review and meta-analysis. Thorax 2011; 66(3):232–239.
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of COPD. 2011 [cited; Available from:http://www.goldcopd.org
   Google Scholar
• ten Brinke A. Risk factors associated with irreversible airflow limitation in asthma. Curr Opin Allergy Clin Immunol 2008; 8:63–69.
   PubMedGoogle Scholar
• Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J 2008; 32(4):962–969.
   PubMed Web of Science ®Google Scholar
• Black P, Larsen F, Ritchie S, Picton T, Wilsher M. Cardiovascular risk factors are increased in patients with severe asthma. Am J Respir Crit Care Med 2004; 169:A356.
   Google Scholar
• Rana JS, Mittleman MA, Sheikh J, Hu FB, Manson JE, Colditz GA, Speizer FE, Barr RG, Camargo CA, Jr. Chronic obstructive pulmonary disease, asthma, and risk of type 2 diabetes in women. Diabetes care 2004; 27(10):2478–2484.
   PubMed Web of Science ®Google Scholar
• Lamprecht B, Schirnhofer L, Kaiser B, Buist S, Studnicka M. Non-reversible airway obstruction in never smokers: Results from the Austrian BOLD study. Respir Med 2008; 102(12):1833–1838.
   PubMed Web of Science ®Google Scholar
• Watz H, Waschki B, Kirsten A, Muller KC, Kretschmar G, Meyer T, Holz O, Magnussen H. The metabolic syndrome in patients with chronic bronchitis and COPD: Frequency and associated consequences for systemic inflammation and physical inactivity. Chest 2009; 136(4):1039–1046.
   PubMed Web of Science ®Google Scholar
• Lawlor DA, Ebrahim S, Smith GD. Associations of measures of lung function with insulin resistance and Type 2 diabetes: Findings from the British Women's Heart and Health Study. Diabetologia 2004; 47(2):195–203.
   PubMed Web of Science ®Google Scholar
• Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson DC, MacIntyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J. Interpretative strategies for lung function tests. Eur Respir J 2005; 26(5):948–968.
   PubMed Web of Science ®Google Scholar
• Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999; 159(1):179–187.
   PubMed Web of Science ®Google Scholar
• Alberti KG, Zimmet P, Shaw J. The metabolic syndrome-a new worldwide definition. Lancet 2005; 366(9491):1059–1062.
   PubMed Web of Science ®Google Scholar
• Fabbri LM, Romagnoli M, Corbetta L, Casoni G, Busljetic K, Turato G, Ligabue G, Ciaccia A, Saetta M, Papi A. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 167(3):418–424.
   PubMed Web of Science ®Google Scholar
• Bumbacea D, Campbell D, Nguyen L, Carr D, Barnes PJ, Robinson D, Chung KF. Parameters associated with persistent airflow obstruction in chronic severe asthma. Eur Respir J 2004; 24(1):122–128.
   PubMed Web of Science ®Google Scholar
• Ulrik CS, Backer V, Dirksen A. A 10 year follow up of 180 adults with bronchial asthma: factors important for the decline in lung function. Thorax 1992; 47(1):14–18.
   PubMed Web of Science ®Google Scholar
• Saha S, Brightling CE. Eosinophilic airway inflammation in COPD. Int J Chron Obstruct Pulmon Dis 2006; 1(1):39–47.
   PubMedGoogle Scholar
• Cowan DC, Cowan JO, Palmay R, Williamson A, Taylor DR. Effects of steroid therapy on inflammatory cell subtypes in asthma. Thorax 2010; 65(5):384–390.
   PubMed Web of Science ®Google Scholar
• Kamfar HZ, Koshak EE, Milaat WA. Is there a role for automated eosinophil count in asthma severity assessment? J Asthma 1999; 36(2):153–158.
   PubMed Web of Science ®Google Scholar
• Celli BR, Halbert RJ, Nordyke RJ, Schau B. Airway obstruction in never smokers: Results from the Third National Health and Nutrition Examination Survey. Am J Med 2005; 118(12):1364–1372.
   PubMed Web of Science ®Google Scholar
• Gottlieb DJ, Sparrow D, O'Connor GT, Weiss ST. Skin test reactivity to common aeroallergens and decline of lung function. The Normative Aging Study. Am J Respir Crit Care Med 1996; 153(2):561–566.
   PubMedGoogle Scholar
• Schayck CPV, Dompeling E, Herwaarden CLV, Wever AM, Weel CV. Interacting effects of atopy and bronchial hyperresponsiveness on the annual decline in lung function and the exacerbation rate in asthma. Am Rev Respir Dis 1991; 144(6):1297–1301.
   PubMedGoogle Scholar
• Burgess JA, Matheson MC, Gurrin LC, Byrnes GB, Adams KS, Wharton CL, Giles GG, Jenkins MA, Hopper JL, Abramson MJ, Walters EH, Dharmage SC. Factors influencing asthma remission: a longitudinal study from childhood to middle age. Thorax 2011; 66(6):508–513.
   PubMed Web of Science ®Google Scholar
• Connolly CK, Chan NS, Prescott RJ. The relationship between age and duration of asthma and the presence of persistent obstruction in asthma. Postgrad Med J 1988; 64(752):422–425.
   PubMed Web of Science ®Google Scholar
• Moore WC, Bleecker ER, Curran-Everett D, Erzurum SC, Ameredes BT, Bacharier L, Calhoun WJ, Castro M, Chung KF, Clark MP, Dweik RA, Fitzpatrick AM, Gaston B, Hew M, Hussain I, Jarjour NN, Israel E, Levy BD, Murphy JR, Peters SP, Teague WG, Meyers DA, Busse WW, Wenzel SE, National Heart LBIsSARP. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol 2007; 119(2):405–413.
   PubMed Web of Science ®Google Scholar
• Miranda C, Busacker A, Balzar S, Trudeau J, Wenzel SE. Distinguishing severe asthma phenotypes: Role of age at onset and eosinophilic inflammation. J Allergy Clin Immunol 2004; 113(1):101–108.
   PubMed Web of Science ®Google Scholar
• Rasmussen F, Taylor DR, Flannery EM, Cowan JO, Greene JM, Herbison GP, Sears MR. Risk factors for airway remodeling in asthma manifested by a low postbronchodilator FEV1/vital capacity ratio: A longitudinal population study from childhood to adulthood. Am J Respir Crit Care Med 2002; 165(11):1480–1488.
   PubMed Web of Science ®Google Scholar
• de Marco R, Marcon A, Jarvis D, Accordini S, Bugiani M, Cazzoletti L, Cerveri I, Corsico A, Gislason D, Gulsvik A, Jõgi R, Martínez-Moratalla J, Pin I, Janson C, Group ECRHST. Inhaled steroids are associated with reduced lung function decline in subjects with asthma with elevated total IgE. J Allergy Clin Immunol 2007; 119(3):611–617.
   PubMedGoogle Scholar
• O'Byrne PM, Pedersen S, Busse WW, Tan WC, Chen Y-Z, Ohlsson SV, Ullman A, Lamm CJ, Pauwels RA, Group STARTI. Effects of early intervention with inhaled budesonide on lung function in newly diagnosed asthma. Chest 2006; 129(6):1478–1485.
   PubMed Web of Science ®Google Scholar
• Beckett PA, Howarth PH. Pharmacotherapy and airway remodelling in asthma? Thorax 2003; 58(2):163–174.
   PubMed Web of Science ®Google Scholar
• Tang MLK, Wilson JW, Stewart AG, Royce SG. Airway remodelling in asthma: Current understanding and implications for future therapies. Pharmacol Ther 2006; 112(2):474–488.
   PubMedGoogle Scholar
• Ward C, Walters H. Airway wall remodelling: the influence of corticosteroids. Curr Opin Allergy Clin Immunol 2005; 5(1):43–48.
   PubMedGoogle Scholar
• Bonacci JV, Harris T, Wilson JW, Stewart AG. Collagen-induced resistance to glucocorticoid anti-mitogenic actions: A potential explanation of smooth muscle hyperplasia in the asthmatic remodelled airway. Br J Pharmacol 2003; 138(7):1203–1206.
   PubMedGoogle Scholar
• Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287(3):356–359.
   PubMed Web of Science ®Google Scholar
• Greenfield JR, Campbell LV. Relationship between inflammation, insulin resistance and type 2 diabetes: ‘Cause or effect’? Curr Diabetes Rev 2006; 2(2):195–211.
   PubMedGoogle Scholar
• Wood LG, Baines KJ, Fu J, Scott HA, Gibson PG. The neutrophilic inflammatory phenotype is associated with systemic inflammation in asthma. Chest 2012; 142:86–93.
   PubMed Web of Science ®Google Scholar
• Sukkar MB, Wood LG, Tooze M, Simpson JL, McDonald VM, Gibson PG, Wark PAB. Soluble RAGE is deficient in neutrophilic asthma and COPD. Eur Respir J 2012; 39(3):721–729.
   PubMed Web of Science ®Google Scholar
• Fuso L, Pitocco D, Longobardi A, Zaccardi F, Contu C, Pozzuto C, Basso S, Varone F, Ghirlanda G, Incalzi RA. Reduced respiratory muscle strength and endurance in type 2 diabetes mellitus. Diabetes Metab Res Rev 2012; 28:370–275.
   PubMed Web of Science ®Google Scholar
• Yeh HC, Punjabi NM, Wang NY, Pankow JS, Duncan BB, Cox CE, Selvin E, Brancati FL. Cross-sectional and prospective study of lung function in adults with type 2 diabetes: The Atherosclerosis Risk in Communities (ARIC) study. Diabetes Care 2008; 31(4):741–746.
   PubMed Web of Science ®Google Scholar
• Goksör E, Åmark M, Alm B, Gustafsson PM, Wennergren G. The impact of pre- and post-natal smoke exposure on future asthma and bronchial hyper-responsiveness. Acta Paediatrica 2007; 96:1030–1035.
   PubMed Web of Science ®Google Scholar
• Hasselgren M, Arne M, Lindahl A, Janson S, Lundbäck B. Estimated prevalences of respiratory symptoms, asthma and chronic obstructive pulmonary disease related to detection rate in primary health care. Scand J Prim Health Care 2001; 19(1):54–57.
   PubMed Web of Science ®Google Scholar
• Mannino DM. GOLD stage 0 COPD: Is it real? Does it matter? Chest 2006; 130(2):309–310.
   Google Scholar
• Brito-Mutunayagam R, Appleton SL, Wilson DH, Ruffin RE, Adams RJ, Team NWACHS. Global Initiative for Chronic Obstructive Lung Disease stage 0 is associated with excess FEV (1) decline in a representative population sample. Chest 2010; 138(3):605–613.
   PubMedGoogle Scholar
• Calverley PMA, Burge PS, Spencer S, Anderson JA, Jones PW. Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax 2003; 58(8):659–664.
   PubMed Web of Science ®Google Scholar
• Perng D-W, Huang H-Y, Chen H-M, Lee Y-C, Perng R-P. Characteristics of airway inflammation and bronchodilator reversibility in COPD: A potential guide to treatment. Chest 2004; 126(2):375–381.
   PubMed Web of Science ®Google Scholar
• Melosini L, Dente FL, Bacci E, Bartoli ML, Cianchetti S, Costa F, Franco AD, Malagrinò L, Novelli F, Vagaggini B, Paggiaro P. Asthma control test (ACT): Comparison with clinical, functional, and biological markers of asthma control. J Asthma 2012; 49(3):317–323.
   PubMed Web of Science ®Google Scholar
• Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M, Gibson P, Ohta K, O’Byrne P, Pedersen SE, Pizzichini E, Sullivan SD, Wenzel SE, Zar HJ. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008; 31(1):143–178.
   PubMed Web of Science ®Google Scholar
• Tai ASN, Tran H, Roberts M, Clarke N, Wilson JW, Robertson CF. Pediatric origins of adult chronic obstructive pulmonary disease (COPD): Childhood asthma. Am J Respir Crit Care Med 2010; 181:A2275.
   Google Scholar
• Finucane KE, Greville HW, Brown PJ. Irreversible airflow obstruction. Evolution in asthma. Med J Aust 1985; 142(11):602–604.
   PubMed Web of Science ®Google Scholar
• Lee JH, Haselkorn T, Borish L, Rasouliyan L, Chipps BE, Wenzel SE. Risk factors associated with persistent airflow limitation in severe or difficult-to-treat asthma: Insights from the TENOR study. Chest 2007; 132(6):1882–1889.
   PubMed Web of Science ®Google Scholar
• Eckel RH, Alberti K, Grundy SM, Zimmet PZ. The metabolic syndrome. The Lancet 2010; 375(9710):181–183.
   PubMed Web of Science ®Google Scholar